Valeant Teams With Bill Ackman to Buy Allergan

April 23 (Bloomberg) -- Valeant offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Stephanie Ruhle reports on Bill Ackman’s involvement on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)
How Does OPEC Today Differ From the 1980s?
33:14 - Bloomberg Intelligence's Vincent Piazza reports on OPEC and the price of oil. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • Is China Growth Number Fiction What Investors Fear Most?
  • The Oldest Woman on Wall Street
  • Here's Why Should Investors Buy Stocks Now